4 unknown. 4 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 4 | Unknown 4 |
Follow Pneumococcal Infections: new trials by email Literature Review of Pneumococcal Infections trials Research Report on Pneumococcal Infections
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase 3 Study to Evaluate the Immunogenicity and Safety of Walvax's PCV13-TT as Compared to Pfizer's PCV13 Walvax PCV13-TT, Pfizer PCV13 - Pneumococcal Disease, Invasive | Phase 3 | Unknown | Walvax Biotechnology Co., Ltd. | 630 | 2023-11-23 | 2024-07-03 |
| Phase III Clinical Trial of 13-valent Pneumococcal Conjugate Vaccine (Multivalent Conjugate) in Infants 13-valent pneumococcal conjugate vaccine (multivalent conjugate), Prevenar 13 - Streptococcus Pneumoniae Infection | Phase 3 | Unknown | Fosun Adgenvax Biopharmaceutical Co.,Ltd. | 1800 | 2022-11-04 | 2024-10-01 |
| Immunogenicity and Safety Study of 15-Valent Pneumococcal Conjugate Vaccine in 2-month-old and 3-month-old Healthy Volunteers 15-Valent Pneumococcal Conjugate Vaccine, 13-Valent Pneumococcal Conjugate Vaccine - Pneumonia, Pneumococcal | Phase 3 | Unknown | Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd | 1950 | 2020-07-01 | 2020-04-22 |
| PneuMum: Pneumococcal Vaccination of Australian Indigenous Mothers to See if it Protects Their Babies From Ear Disease 23 valent pneumococcal polysaccharide vaccine - Middle Ear Effusion, Tympanic Membrane Perforation | Phase 3 | Unknown | University of Melbourne | 210 | 2006-03-01 | 2007-12-13 |
Otitis Media (1) · Otitis Media with Effusion (1) · Pneumonia, Pneumococcal (1) · Tympanic Membrane Perforation (1)
Bacterial Infections (4) · Bacterial Infections and Mycoses (4) · Gram-Positive Bacterial Infections (4) · Infections (4) · Streptococcal Infections (4) · Ear Diseases (1) · Lung Diseases (1) · Otitis (1) · Otorhinolaryngologic Diseases (1) · Pneumonia (1) · Pneumonia, Bacterial (1) · Respiratory Tract Diseases (1) · Respiratory Tract Infections (1) · Wounds and Injuries (1)
13-valent pneumococcal vaccine (1) · 23-valent pneumococcal capsular polysaccharide vaccine (1)
Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd (1) · Fosun Adgenvax Biopharmaceutical Co.,Ltd. (1) · University of Melbourne (1) · Walvax Biotechnology Co., Ltd. (1)
China (2) · Australia (1) · Indonesia (1)
Amanda J Leach, PhD (1) · Du Lin, Master (1) · Edward K Mulholland, DM (1) · Jonathan R Carapetis, PhD (1) · Peter S Morris, PhD (1) · Ross M Andrews, PhD (1)